Thank you for Subscribing to CIO Applications Weekly Brief

Life Sciences Driven by Artificial Intelligence
AI can find its application in the various phases of discovery and development of drugs, ranging from synthesizing and designing drugs organically to molecular design automation.
By
CIO Applications | Friday, November 30, 2018

With the extensive and risky drug development lifecycle, it takes close to a decade or more to develop an effective drug. Moreover, only 12 percent gain approval in clinical trials. As the technology has taken over almost every industry, life science places its bet on artificial intelligence (AI) to help companies reduce the time spent on R&D for new drugs.
With time, several blue-sky thinkers and angel investors have placed their money on the AI-based life science startups. AI in the pharmaceutical and biotechnological industry is presently deciphering the drug discovery phase. With the involvement of AI, discovering drugs can enter a new paradigm which can result in huge cost savings.
AI can find its application in the various phases of discovery and development of drugs, ranging from synthesizing and designing drugs organically to molecular design automation. It can also play a role in toxicity prediction prior to clinical trials and personalized medications.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Check Out: Life Sciences Review
Recently a research-based from Stanford could conceptualize and design a methodology of drug discovery that can reduce the time and data needed in identifying newer drugs, through one-time learning. In MIT, a consortium named ‘Machine Learning for Pharmaceutical Discovery and Synthesis’ was formed while collaborating with organizations that are playing it big in the industry.
The presence of AI has made the current era the most opportune for biotechnology and pharmaceutical organizations to reap immense innovations. U.S. based organizations spend over $75 billion each year only for R&D. While startups and large enterprise are investing a significant amount of time and money into technological solutions pertaining to AI, many research and studies are underway to understand and unveil other means to reduce the time taken for drug development.
Check This Out: Top Drug Discovery and Development Solution Companies
More in News

